
Sign up to save your podcasts
Or


I sit down with John Miley, Associate Editor with The Kiplinger Letter with a special focus on technology.
This is the second of three interviews with John. Each interview lasts around 20 minutes and focus on 5G Technology, Augmented and Virtual Reality, and Drones and Robots respectively.
For each podcast, John shares details about where each technology stands, where it appears to be heading, what companies will be most impacted, and what it will mean for the economy and consumers.
A quick overview of our second interview:
Companies mentioned: Google (GOOG), Apple (AAPL), Facebook (FB), Intel (INTC), Texas Instruments (TXN), Samsung, Sony (SNE), HTC, Lenovo, AT&T (T), Verizon (VZ), Comcast (CMCSA)
I hope you enjoy this second of three interviews with John Miley from The Kiplinger Letter.
I sit down with John Miley, Associate Editor with The Kiplinger Letter with a special focus on tech.
This is the first of three interviews with John. Each interview lasts around 20 minutes and focus on 5G Technology, Augmented and Virtual Reality, and Drones and Robots respectively.
For each podcast, John shares details about where each technology stands, where it appears to be heading, what companies will be most impacted, and what it will mean for the economy and consumers.
A quick overview of our first interview:
Companies mentioned: AT&T (T), Verizon (VZ), T-Mobile (TMUS), Sprint (S), Ericsson (ERIC), Huawei, Samsung, Cisco (CSCO), Qualcomm (QCOM), Juniper (JNPR), Intel (INTC), Apple (AAPL), Google (GOOG), Facebook (FB)
I hope you enjoy this first of three interviews with John Miley from The Kiplinger Letter.
I hope you enjoy my overview of Randall Forsyth’s Up & Down Wall Street column from this week’s Barron’s magazine.
In it, I discuss what some are calling “peak liquidity” and a turning point in Central Bank crisis policies.
Overview
http://investorinthefamily.com/
Bret Jensen is one of my favorite resources when it comes to biotech investing.
We sat down a few days ago to discuss some of his favorite small cap biotech companies that have near term (mostly 4Q) catalysts.
A quick preview:
Companies mentioned: Pfizer (PFE), AstraZeneca (AZN), Allergan (AGN), Egalet (EGLT), Synergy (SGYP), Portola (PTLA), Dynavax (DVAX), Cempra (CEMP)
I hope you enjoy the interview.
Dirk Leach has been a consistent, avid, and successful investor for more than 30 years. His style is conservative and he primarily focuses on income oriented equities, bonds, preferred stocks and mutual funds.
In this interview, we have a follow-up conversation to an article Dirk wrote recently by the same title.
I appreciated his article and was glad for the chance to discuss it more and share that with you here.
A quick preview:
Companies and funds mentioned: S&P 500 (SPY), Vanguard Dividend Growth Fund Inv (NYSE: VDIGX), Vanguard Health Care Fund Inv (NYSE: VGHCX), Vanguard Energy Fund Inv (NYSE: VGENX), Vanguard Windsor II Fund Inv (NYSE: VWNFX), Vanguard Global Equity Fund Inv (NYSE: VHGEX)
I hope you enjoy the interview.
Adam Aloisi joins me to discuss Closed End Funds (CEFs). What are they, how do they work and what opportunity (or threat) do they presently offer?
A quick preview:
I hope you enjoy the interview.
Adam Aloisi and I sit down to discuss dividend stocks. Specifically, we talk about how risky dividends are at today's valuations.
A brief overview:
I hope you enjoy the interview.
Overview
http://investorinthefamily.com/
Overview
http://investorinthefamily.com/
Doug Eberhardt is the some of a commodities trader and has been working with gold and silver for years. Doug was kind enough to sit down with me and let me pick his brain for a few minutes.
A few highlights:
http://investorinthefamily.com/
From the publisher's feed

1,715 Listeners

4,343 Listeners